Ask AI
ProCE Banner Activity

CE / CME

Owning Obesity in Psoriasis Care: A Multisite Quality Improvement Initiative to Improve Obesity Care for Patients With Psoriasis in Dermatology Settings

Video

Obesity and psoriasis share a complex, bidirectional relationship that has implications in dermatology practice, including the chronic inflammatory state of obesity and how that impacts psoriasis treatment strategies. Learn how to provide evidence-based care when screening patients and individualizing treatment planning, while engaging in compassionate, patient-centered conversations about weight and metabolic health.

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Pharmacists: 1.00 contact hour (0.1 CEUs)

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Nurse Practitioners/Nurses: 1.00 Nursing contact hour

Released: September 16, 2026

Expiration: September 15, 2027

Share

Provided by

 Provided by Clinical Care Options, LLC in partnership with the National Psoriasis Foundation (NPF) and Q Synthesis.

ProCE Banner

Supporters

This initiative is supported by an independent grant from Lilly.

Lilly

Partners

National Psoriasis Foundation (NPF)

ProCE Banner

Q Synthesis

ProCE Banner

Target Audience

Dermatologists, nurse practitioners, pharmacists, and physician associates who manage patients with psoriasis. 

Program Learning Goal

The goal of this activity is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Psoriasis.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Evaluate the correlation between PsO, obesity, and systemic inflammation

  • Execute recommended screening and management practices for obesity in patients with PsO

  • Lead clear, compassionate, and culturally sensitive conversations with patients around weight and metabolic health

  • Design patient-centered, personalized management plans for patients with PsO and obesity

Financial Disclosures

Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

April W. Armstrong, MD, MPH: researcher: AbbVie, Alumis, Bristol Myers Squibb, Galderma, Janssen, Novartis, Takeda; consultant/advisor/speaker: AbbVie, Amgen, Arcutis, Bristol Myers Squibb, Dermavant, Galderma, Incyte, Janssen, Leo, Lilly, Novartis, Ortho Derm, Pfizer, Regeneron, Sanofi, UCB; data and safety monitoring board: Boehringer Ingelheim.

Foday Koroma, FNP-BC: consultant/advisor/speaker: AbbVie, Sun.

Joseph F. Merola, MD, MMSc, FAAD, FACR: consultant and/or investigator: AbbVie, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Galderma, Janssen, Lilly, Moonlake, Novartis, Oruka, Pfizer, Sanofi, Regeneron, Sun, UCB.

The planners and content peer reviewers from Decera Clinical Education, the National Psoriasis Foundation (NPF) and Q Synthesis do not have any relevant financial relationships to disclose, except Foday Koroma, FNP-BC, as noted below:

Foday Koroma, FNP-BC consultant/advisor/speaker: AbbVie, Sun.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from September 16, 2026, through September 15, 2027:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Additional Disclosures

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Generative artificial intelligence (AI) tools were used for generating transcript(s) from audio/video file. All AI-assisted content underwent human review, editing, and validation by qualified faculty and accredited education staff to ensure scientific accuracy, balance, and compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education.

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC dba Decera Clinical Education and the National Psoriasis Foundation (NPF) and Q Synthesis. Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour.

Continuing Pharmacy Education

Clinical Care Options, LLC dba Decera Clinical Education designates this continuing education activity for 1 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-9999-26-543-H01-P 

Type of Activity: Application

Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credit. Approval is valid until September 15, 2027. PAs should only claim credit commensurate with the extent of their participation.

IPCE Credit Designation

A logo for a credit companyAI-generated content may be incorrect.

This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.